Outset Medical, Inc. (OM) stock
OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3068% below fair value
$3.86−0.31 (-7.43%)
Close on Nov 12, 2026Market cap $72.56MP/E –Yield –
Outset Medical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Outset Medical's profit margin for the twelve months ending Sep 30, 2026 was -58.3%. For fiscal 2025 it was -68.3%, against -112.6% the year before. The highest annual figure on record is -68.3% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -68.3% | +44.2 |
| FY2024 | Dec 31, 2024 | -112.6% | +20.0 |
| FY2023 | Dec 31, 2023 | -132.5% | +8.7 |
| FY2022 | Dec 31, 2022 | -141.2% | −12.7 |
| FY2021 | Dec 31, 2021 | -128.6% | +114.7 |
| FY2020 | Dec 31, 2020 | -243.3% | +209.7 |
| FY2019 | Dec 31, 2019 | -453.0% | +2027.3 |
| FY2018 | Dec 31, 2018 | -2480.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -43.7% | +16.9 |
| Q2 FY2026 | Jun 30, 2026 | -56.8% | +2.2 |
| Q1 FY2026 | Mar 31, 2026 | -68.1% | +18.5 |
| Q4 FY2025 | Dec 31, 2025 | -67.5% | +19.5 |
| Q3 FY2025 | Sep 30, 2025 | -60.6% | +36.9 |
| Q2 FY2025 | Jun 30, 2025 | -59.0% | +66.8 |
| Q1 FY2025 | Mar 31, 2025 | -86.7% | +55.1 |
| Q4 FY2024 | Dec 31, 2024 | -87.0% | +39.5 |
| Q3 FY2024 | Sep 30, 2024 | -97.5% | +54.6 |
| Q2 FY2024 | Jun 30, 2024 | -125.8% | −3.6 |
| Q1 FY2024 | Mar 31, 2024 | -141.8% | −10.4 |
| Q4 FY2023 | Dec 31, 2023 | -126.5% | +3.0 |
| Q3 FY2023 | Sep 30, 2023 | -152.1% | −5.2 |
| Q2 FY2023 | Jun 30, 2023 | -122.2% | +52.7 |
| Q1 FY2023 | Mar 31, 2023 | -131.4% | −10.6 |
| Q4 FY2022 | Dec 31, 2022 | -129.5% | +17.0 |
| Q3 FY2022 | Sep 30, 2022 | -146.9% | −31.1 |
| Q2 FY2022 | Jun 30, 2022 | -175.0% | −55.2 |
| Q1 FY2022 | Mar 31, 2022 | -120.8% | +10.3 |
| Q4 FY2021 | Dec 31, 2021 | -146.5% | +39.3 |
| Q3 FY2021 | Sep 30, 2021 | -115.8% | +191.7 |
| Q2 FY2021 | Jun 30, 2021 | -119.8% | +105.9 |
| Q1 FY2021 | Mar 31, 2021 | -131.0% | +156.2 |
| Q4 FY2020 | Dec 31, 2020 | -185.8% | +88.7 |
| Q3 FY2020 | Sep 30, 2020 | -307.5% | +278.2 |
| Q2 FY2020 | Jun 30, 2020 | -225.7% | +367.2 |
| Q1 FY2020 | Mar 31, 2020 | -287.2% | +372.0 |
| Q4 FY2019 | Dec 31, 2019 | -274.5% | – |
| Q3 FY2019 | Sep 30, 2019 | -585.6% | – |
| Q2 FY2019 | Jun 30, 2019 | -592.9% | – |
| Q1 FY2019 | Mar 31, 2019 | -659.3% | – |
See a number that looks wrong?